Methodology Protocol

You have free access to this content

Eliciting adverse effects data from participants in clinical trials

  1. Elizabeth N Allen1,*,
  2. Clare IR Chandler2,
  3. Nyaradzo Mandimika1,
  4. Karen Barnes3

Editorial Group: Cochrane Methodology Review Group

Published Online: 31 MAY 2013

Assessed as up-to-date: 11 MAR 2012

DOI: 10.1002/14651858.MR000039


How to Cite

Allen EN, Chandler CIR, Mandimika N, Barnes K. Eliciting adverse effects data from participants in clinical trials (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.: MR000039. DOI: 10.1002/14651858.MR000039.

Author Information

  1. 1

    University of Cape Town, Division of Clinical Pharmacology, Dept of Medicine, Cape Town, Western Cape, South Africa

  2. 2

    London School of Hygiene and Tropical Medicine, Dept of Global Health & Development, London, UK

  3. 3

    University of Cape Town, Division of Clinical Pharmacology, Cape Town, South Africa

*Elizabeth N Allen, Division of Clinical Pharmacology, Dept of Medicine, University of Cape Town, K45, Old Main Building, Groote Schuur Hospital, Observatory, Cape Town, Western Cape, 7925, South Africa. elizabeth.allen@uct.ac.za.

Publication History

  1. Publication Status: New
  2. Published Online: 31 MAY 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To systematically review available literature on research that compares the methods used within, or specific for, clinical drug trials/studies to elicit information from the participants about the AEs that were defined in the protocol or in the preparation for the trial.